Consistent with these results, the p53-dependent GLS2 upregulation and its tumor suppressive role in HCC was associated with mitochondrial activation and enhanced antioxidant defense20,21 and, more recently, with inhibition of Rac1 activation and metastasis suppression38. The gene discussed is GLS2; the disease is hepatocellular carcinoma.